SEARCH

SEARCH BY CITATION

References

  • 1
    Busch MP. Closing the windows on viral transmission by blood transfusion. In: StramerSL, ed. Blood Safety in the New Millennium. Bethesda: American Association of Blood Banks, 2001: 3354.
  • 2
    Seeff LB, Hollinger FB, Alter HJ, Wright EC, Cain CM, Buskell ZJ, et al. Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: a National Heart, Lung and Blood Institute collaborative study. HEPATOLOGY 2001; 33: 455463.
  • 3
    Mosley JW, Aach RD, Hollinger FB, Stevens CE, Barbosa LH, Nemo GJ, et al. Non-A, non-B hepatitis and antibody to hepatitis C virus. JAMA 1990; 263: 777781.
  • 4
    Mimms LT, Mosley JW, Hollinger FB, Aach RD, Stevens CE, Cunningham M, et al. Transfusion-transmitted co-infection with human hepatitis B and hepatitis C viruses. BMJ 1993; 307: 10951097.
  • 5
    Mosley JW, Huang W, Stram DO, Nowicki MJ, Hollinger FB, Aach RD, et al. Donor levels of serum alanine aminotransferase activity and antibody to hepatitis B core antigen associated with recipient hepatitis C and non-B, non-C outcomes. Transfusion 1996; 36: 776781.
  • 6
    Lin HJ, Seeff LB, Barbosa L, Hollinger FB. Occurrence of identical hypervariable region 1 sequences of hepatitis C virus in transfusion recipients and their respective blood donors: divergence over time. HEPATOLOGY 2001; 34: 424429.
  • 7
    Operskalski EA, Mosley JW, Tobler LH, Fiebig EW, Nowicki MJ, Mimms LT, et al. HCV viral load in anti-HCV-reactive donors and infectivity for their recipients. Transfusion 2003; 43: 14331441.
  • 8
    Aach RD, Szmuness W, Mosley JW, Hollinger FB, Kahn RA, Stevens CE, et al. Serum alanine aminotransferase of donors in relation to the risk of non-A, non-B hepatitis in recipients: the Transfusion-Transmitted Viruses Study. N Engl J Med 1981; 304: 989994.
  • 9
    Stevens CE, Aach RD, Hollinger FB, Mosley JW, Szmuness W, Kahn R, et al. Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients: an analysis of the Transfusion-Transmitted Viruses Study. Ann Intern Med 1984; 101: 733738.
  • 10
    Hollinger FB, Mosley JW, Szmuness W, Aach RD, Melnick JL, Afifi A, et al. Non-A, non-B hepatitis following blood transfusion: risk factors associated with donor characteristics. In: SzmunessW, AlterHJ, MaynardJE, eds. Viral Hepatitis; 1981 International Symposium. Philadelphia: Franklin Institute Press, 1982: 361376.
  • 11
    Mosley JW, Goodwin RG. Stability of serum glutamic pyruvic transaminase activity on storage. Am J Clin Pathol 1965; 44: 591595.
  • 12
    Giachetti C, Linnen J, Kolk DP, Dockter J, Gillotte-Taylor K, Park M, et al. Highly sensitive multiplex assay for detection of HIV-1 and HCV RNA. J Clin Microbiol 2002; 40: 17611766.
  • 13
    JMLast, ed. A Dictionary of Epidemiology. New York: Oxford University Press, 1983: 49.
  • 14
    Esteban JI, Cordoba J, Sauleda S. The clinical picture of acute and chronic hepatitis C. In: ReesinkHW, ed. Hepatitis C Virus. 2nd ed. Basel: Karger, 1998: 102118.
  • 15
    Prince AM, Brotman B, Grady GF, Kuhns WJ, Hazzi C, Levine RW, et al. Long-incubation post-transfusion hepatitis without serological evidence of exposure the hepatitis-B virus. Lancet 1974; 2: 241246.
  • 16
    Alter HJ, Holland PV, Morrow AG, Purcell RH, Feinstone SM, Moritsugu Y. Clinical and serological analysis of transfusion-associate hepatitis. Lancet 1975; 2: 838841.
  • 17
    Seeff LB, Wright EC, Zimmerman HJ, McCollum RW. VA cooperative study of post-transfusion hepatitis, 1969–1974: incidence and characteristics of hepatitis and responsible risk factors. Am J Med Sci 1975; 270: 355362.
  • 18
    Seeff LB, Miller RN, Rabkin CS, Buskell-Bales Z, Straley-Eason KD, Smoak BL, et al. 45-year follow-up of hepatitis C virus infection in healthy young adults. Ann Intern Med 2000; 132: 105111.
  • 19
    Dockter J, Schneider W, Cox D, Millar C, McDonough S, Giachetti C. Long term stability of HIV-1 and HCV specimens collected in different anticoagulants and stored at −20°C or −70°C. Transfusion 2003; 41(Suppl): 121A122A.
  • 20
    Thimme R, Bukh J, Spangenberg HC, Wieland S, Pemberton J, Steiger C, et al. Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. Proc Natl Acad Sci 2002; 99: 1566115668.
  • 21
    Thimme R, Oldach D, Chang K-M, Steiger C, Ray SC, Chisari FV. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Emerg Med 2001; 194: 13951406.
  • 22
    Roizman B, Palese P. Multiplication of viruses: an overview. In: FieldsBN, KnipeDM, HowleyPM, eds. Fields Virology. 3rd ed. Philadelphia, Lippincott-Raven, 1996: 102.
  • 23
    Garcia-Retortillo M, Forns X, Feliu A, Moitinho E, Costa J, Navasa M, et al. Hepatitis C virus kinetics during and immediately after liver transplantation. HEPATOLOGY 2002; 35: 680687.
  • 24
    Glynn SA, Wright DJ, Kleinman SH, Hirschkorn H, Tu Y, Heldebrant C, et al. Dynamics of viremia in early hepatitis C virus infection. Transfusion (in press).
  • 25
    Huang S-J, Lee S-D, Lu R-H, Chu CW, Wu JC, Lai S-T, et al. Hepatitis C viral genotype influences the clinical outcome of patients with acute posttransfusion hepatitis C. J Med Virol 2001; 65: 505509.
  • 26
    Santantonio T, Sinisi E, Guastadisegni A, Casalino C, Mazzola M, Gentile A, et al. Natural course of acute hepatitis C: a long-term prospective study. Dig Liver Dis 2003; 35: 104113.